SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging following a blowout earnings report characterized by massive data center growth and strong AI infrastructure demand, with analysts aggressively raising price targets. The community is buzzing with excitement over the stock's parabolic move, fueling intense debate between retail bulls celebrating a "generational" trend and skeptics pointing to soaring valuation multiples and signs of market irrationality.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market sentiment surrounding the Invesco QQQ Trust remains intensely bullish, driven by strong earnings momentum in the semiconductor sector and widespread speculation regarding potential peace talks in the Middle East. Community discourse is highly polarized, with many investors riding the rapid upward trajectory while a vocal segment warns of a potential bubble given the swift pace of recent gains.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 continues to rally as markets react to headlines regarding a potential pause in U.S. military efforts in the Strait of Hormuz, with community sentiment deeply polarized between bullish momentum traders chasing AI-driven gains and bearish voices citing concerns over valuation, inflation, and the legitimacy of recent geopolitical announcements.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Investors are actively debating the recent stagnation of NVDA while competitors surge, with many speculating that heavy institutional pinning and capital rotation are suppressing the stock ahead of upcoming earnings. Despite the broader AI sector momentum, the community remains divided between those viewing the current price action as a strategic buying opportunity and those concerned that the stock is losing leadership to memory and CPU-focused chipmakers.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as retail and institutional investors pile into the stock, fueled by unprecedented demand for memory chips in AI data centers and ongoing excitement over new high-capacity product announcements. While the community is debating whether this parabolic rally represents a sustainable shift in memory sector fundamentals or a classic bubble, many investors are actively discussing potential stock splits and aggressive price targets as Micron hits new highs.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Semiconductor investors are engaged in a high-stakes standoff as the market's relentless momentum drives the sector to historic valuation levels, leaving those positioned for a reversal frustrated by persistent after-hours gains. The community is actively debating the sustainability of this melt-up, with many expressing skepticism over disconnected earnings and recycled headlines while others warn that the aggressive nature of leveraged ETFs makes timing a correction particularly dangerous.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing a massive, parabolic price surge driven by severe NAND flash and DRAM supply shortages, with AI data center demand keeping the memory supercycle in high gear through at least 2027. The community is sharply divided, with bulls celebrating life-changing gains and betting on structural market dominance, while skeptical bears warn of a classic bubble fueled by extreme valuation disconnects and speculative euphoria.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending after a significant surge in after-hours trading driven by an earnings beat and strong margin recovery, which has largely eased concerns regarding profitability and prior accounting-related overhangs. The community is actively debating the stock's potential for a massive short squeeze given high short interest, while some remain cautious about management's communication style and ongoing institutional skepticism despite the company's robust data center infrastructure growth.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is rallying following a landmark 10-year AI data center contract with Cerebras Systems, fueling community optimism about a significant valuation gap and potential for future expansion. While retail investors are actively sharing bullish targets and calling for a short squeeze, some market participants remain cautious due to the stock's historical volatility and speculative nature.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors pivot toward the potential of its oral Wegovy pipeline, with community sentiment shifting positively following reports of manufacturing scale and a widening efficacy gap between its oral franchise and competitors' small-molecule alternatives. The conversation is primarily focused on the upcoming earnings report and the strategic launch of the Ozempic tablet, with many anticipating that strong volume data will validate a reversal in the stock's recent downtrend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday

CytomX Therapeutics (NASDAQ:CTMX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-cytomx-therapeutics-inc-stock...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Analysts

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and nine have assigned...

Wall Street Zen Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Strong Sell

Wall Street Zen lowered shares of CytomX Therapeutics from a "sell" rating to a "strong sell" rating in a research note on Saturday...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Crosses Below 50-Day Moving Average - Here's What Happened

CytomX Therapeutics (NASDAQ:CTMX) Share Price Passes Below 50-Day Moving Average - What's Next...

Traders Buy High Volume of CytomX Therapeutics Put Options (NASDAQ:CTMX)

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) was the recipient of some unusual options trading activity on Thursday. Stock traders acquired 13,090 put options on the company. This...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 6.3%  - Time to Buy?

CytomX Therapeutics (NASDAQ:CTMX) Trading Up 6.3% - What's Next...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Brokerages

Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten brokerages that are covering the stock, MarketBeat Ratings...

Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

CytomX Therapeutics (NASDAQ:CTMX) Trading 4.9% Higher - Should You Buy?

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 4.9% - Should You Buy...

CytomX Therapeutics (NASDAQ:CTMX) Given New $12.00 Price Target at Piper Sandler

Piper Sandler upped their target price on shares of CytomX Therapeutics from $10.00 to $12.00 and gave the stock an "overweight" rating in a report on Monday...

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

CytomX Therapeutics Inc

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

CTMX
CytomX Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTMX News

CTMXCytomX Therapeutics Inc